Breast Cancer
November 19
4 min read
The next-generation Oncodetect assay combines tumor-informed whole-genome sequencing with MAESTRO (Minor Allele Enriched Sequencing Through Recognition Oligonucleotides), a technology originally developed by researchers at the Broad Institute of MIT and Harvard.